Medical cannabis and cannabis provisions modified.

HF 1877 amends Minnesota's medical cannabis laws by updating key definitions and adding new requirements for patient enrollment and manufacturer registration. The bill prohibits patients enrolled in federally approved clinical trials for a qualifying medical condition from joining the medical cannabis registry and requires the commissioner to inform patients about such trials as an alternative. It revises the process for registering medical cannabis manufacturers, mandating two in-state manufacturers to be registered by December 1 every two years, with the commissioner considering factors like technical expertise and financial stability. These changes directly affect patients seeking medical cannabis, healthcare providers who certify conditions, and the businesses that produce and distribute medical cannabis in Minnesota.